Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

100 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Substitution of nevirapine, efavirenz, or abacavir for protease inhibitors in patients with human immunodeficiency virus infection.
Martínez E, Arnaiz JA, Podzamczer D, Dalmau D, Ribera E, Domingo P, Knobel H, Riera M, Pedrol E, Force L, Llibre JM, Segura F, Richart C, Cortés C, Javaloyas M, Aranda M, Cruceta A, de Lazzari E, Gatell JM; Nevirapine, Efavirenz, and Abacavir (NEFA) Study Team. Martínez E, et al. Among authors: arnaiz ja. N Engl J Med. 2003 Sep 11;349(11):1036-46. doi: 10.1056/NEJMoa021589. N Engl J Med. 2003. PMID: 12968087 Free article. Clinical Trial.
Interleukin-2 therapy in patients with HIV infection.
INSIGHT-ESPRIT Study Group; SILCAAT Scientific Committee; Abrams D, Lévy Y, Losso MH, Babiker A, Collins G, Cooper DA, Darbyshire J, Emery S, Fox L, Gordin F, Lane HC, Lundgren JD, Mitsuyasu R, Neaton JD, Phillips A, Routy JP, Tambussi G, Wentworth D. INSIGHT-ESPRIT Study Group, et al. N Engl J Med. 2009 Oct 15;361(16):1548-59. doi: 10.1056/NEJMoa0903175. N Engl J Med. 2009. PMID: 19828532 Free PMC article. Clinical Trial.
Maraviroc, as a Switch Option, in HIV-1-infected Individuals With Stable, Well-controlled HIV Replication and R5-tropic Virus on Their First Nucleoside/Nucleotide Reverse Transcriptase Inhibitor Plus Ritonavir-boosted Protease Inhibitor Regimen: Week 48 Results of the Randomized, Multicenter MARCH Study.
Pett SL, Amin J, Horban A, Andrade-Villanueva J, Losso M, Porteiro N, Sierra Madero J, Belloso W, Tu E, Silk D, Kelleher A, Harrigan R, Clark A, Sugiura W, Wolff M, Gill J, Gatell J, Fisher M, Clarke A, Ruxrungtham K, Prazuck T, Kaiser R, Woolley I, Arnaiz JA, Cooper D, Rockstroh JK, Mallon P, Emery S; Maraviroc Switch (MARCH) Study Group. Pett SL, et al. Among authors: arnaiz ja. Clin Infect Dis. 2016 Jul 1;63(1):122-32. doi: 10.1093/cid/ciw207. Epub 2016 Apr 5. Clin Infect Dis. 2016. PMID: 27048747 Free PMC article. Clinical Trial.
Development and validation of a risk score for chronic kidney disease in HIV infection using prospective cohort data from the D:A:D study.
Mocroft A, Lundgren JD, Ross M, Law M, Reiss P, Kirk O, Smith C, Wentworth D, Neuhaus J, Fux CA, Moranne O, Morlat P, Johnson MA, Ryom L; D:A:D study group; Royal Free Hospital Clinic Cohort; INSIGHT study group; SMART study group; ESPRIT study group. Mocroft A, et al. PLoS Med. 2015 Mar 31;12(3):e1001809. doi: 10.1371/journal.pmed.1001809. eCollection 2015 Mar. PLoS Med. 2015. PMID: 25826420 Free PMC article.
Safety and immunogenicity of a recombinant protein RBD fusion heterodimer vaccine against SARS-CoV-2.
Leal L, Pich J, Ferrer L, Nava J, Martí-Lluch R, Esteban I, Pradenas E, Raïch-Regué D, Prenafeta A, Escobar K, Pastor C, Ribas-Aulinas M, Trinitè B, Muñoz-Basagoiti J, Domenech G, Clotet B, Corominas J, Corpes-Comes A, Garriga C, Barreiro A, Izquierdo-Useros N, Arnaiz JA, Soriano A, Ríos J, Nadal M, Plana M, Blanco J, Prat T, Torroella E, Ramos R; HIPRA-HH-1 study group. Leal L, et al. Among authors: arnaiz ja. NPJ Vaccines. 2023 Sep 29;8(1):147. doi: 10.1038/s41541-023-00736-5. NPJ Vaccines. 2023. PMID: 37775521 Free PMC article.
The recovery of European freshwater biodiversity has come to a halt.
Haase P, Bowler DE, Baker NJ, Bonada N, Domisch S, Garcia Marquez JR, Heino J, Hering D, Jähnig SC, Schmidt-Kloiber A, Stubbington R, Altermatt F, Álvarez-Cabria M, Amatulli G, Angeler DG, Archambaud-Suard G, Jorrín IA, Aspin T, Azpiroz I, Bañares I, Ortiz JB, Bodin CL, Bonacina L, Bottarin R, Cañedo-Argüelles M, Csabai Z, Datry T, de Eyto E, Dohet A, Dörflinger G, Drohan E, Eikland KA, England J, Eriksen TE, Evtimova V, Feio MJ, Ferréol M, Floury M, Forcellini M, Forio MAE, Fornaroli R, Friberg N, Fruget JF, Georgieva G, Goethals P, Graça MAS, Graf W, House A, Huttunen KL, Jensen TC, Johnson RK, Jones JI, Kiesel J, Kuglerová L, Larrañaga A, Leitner P, L'Hoste L, Lizée MH, Lorenz AW, Maire A, Arnaiz JAM, McKie BG, Millán A, Monteith D, Muotka T, Murphy JF, Ozolins D, Paavola R, Paril P, Peñas FJ, Pilotto F, Polášek M, Rasmussen JJ, Rubio M, Sánchez-Fernández D, Sandin L, Schäfer RB, Scotti A, Shen LQ, Skuja A, Stoll S, Straka M, Timm H, Tyufekchieva VG, Tziortzis I, Uzunov Y, van der Lee GH, Vannevel R, Varadinova E, Várbíró G, Velle G, Verdonschot PFM, Verdonschot RCM, Vidinova Y, Wiberg-Larsen P, Welti EAR. Haase P, et al. Among authors: arnaiz jam. Nature. 2023 Aug;620(7974):582-588. doi: 10.1038/s41586-023-06400-1. Epub 2023 Aug 9. Nature. 2023. PMID: 37558875 Free PMC article.
100 results